Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ophthalmic Solution

Known as: Ophthalmic Solution [Dose Form], Ophthalmic Solutions, Solutions, Ophthalmic 
A sterile solution containing a particular pharmaceutical agent administered to the external eye, usually in the form of droplets. An ophthalmic… Expand
National Institutes of Health

Related topics

Related topics

50 relations
Brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan]Carboxymethylcellulose Sodium 5 MG/ML / Glycerin 9 MG/ML Ophthalmic SolutionCarboxymethylcellulose Sodium 5 MG/ML Ophthalmic SolutionCiprofloxacin 3 MG/ML Ophthalmic Solution
Expand

Broader (1)

OPHTHALMIC AGENTS

Narrower (2)

Water 991 MG/ML Ophthalmic Irrigation Solutionlifitegrast

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
PURPOSE To assess the efficacy and safety of lifitegrast ophthalmic solution 5.0% compared with placebo in subjects with dry eye… Expand
Highly Cited
2012
Highly Cited
2012
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
Aims To compare the efficacy and safety of 3% diquafosol ophthalmic solution with those of 0.1% sodium hyaluronate ophthalmic… Expand
Highly Cited
2010
Highly Cited
2010
Multicenter Open-Label Study Evaluating the Efficacy of Azithromycin Ophthalmic Solution 1% on the Signs and Symptoms of Subjects With Blepharitis
Purpose: To evaluate the effect of 4 weeks of treatment with azithromycin ophthalmic solution 1% on eyelid bacterial load, tear… Expand
Highly Cited
2010
Highly Cited
2010
pH dependent spectral properties of sodium fluorescein ophthalmic solutions revisited
  • M. Doughty
  • Ophthalmic & physiological optics : the journal…
  • 2010
    • Corpus ID: 205636266
Purpose:  To re‐assess and further quantify the pH‐related changes in the absorbance and fluorescence emission spectra of sodium… Expand
Highly Cited
2008
Highly Cited
2008
Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells
Purpose:  The cytotoxicity of a range of commercial ophthalmic solutions in the presence and absence of preservatives was… Expand
Highly Cited
2007
Highly Cited
2007
Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
Conventional ophthalmic solutions often eliminate rapidly after administration and cannot provide and maintain an adequate… Expand
Highly Cited
2005
Highly Cited
2005
Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients.
PURPOSE To measure the achievable perioperative aqueous concentration of the commercially available topically administered fourth… Expand
Highly Cited
1996
Highly Cited
1996
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
PURPOSE The purpose of the study is to compare the clinical efficacy and safety of ciprofloxacin ophthalmic solution 0.3… Expand
Highly Cited
1991
Highly Cited
1991
Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis.
  • H. Leibowitz
  • American journal of ophthalmology
  • 1991
    • Corpus ID: 26008783
A multicenter, prospective clinical study of 148 culture-proven cases of bacterial keratitis, treated with ciprofloxacin 0.3… Expand
Highly Cited
1976
Highly Cited
1976
Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.
Timolol ophthalmic solutions 0.5 per cent, 1.0 per cent, and 1.5 per cent lowered intraocular pressures significantly in normal… Expand
  • table I
  • table I
  • table II
  • table III
  • table IV
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE